Cancer is a leading cause of death worldwide, accounting for about 10 million and 3.2 million deaths in the world and China in 2022, respectively. Despite extensive studies in the past several decades, many fundamental questions in cancer biology remain poorly understood, including transition from pre-malignancy to tumor, clonal evolution & plasticity, intra-tumor heterogeneity, tumor-stroma interaction, mechanisms for metastasis, therapeutic resistance and the immune microenvironment. As such, comprehensive analysis and interpretation of cancer properties require not only precise investigations, but also collaborative efforts worldwide.
The goal of this symposium is to bring together a diverse range of world-leading cancer biologists and physician scientists to discuss the latest developments, cutting-edge and hot issues in the fields. The attendees from all levels of expertise are encouraged to contribute by participating in discussion. We hope that the symposium serves as a platform for interactions, thereby promoting collaborations to solve the most challenging problems in cancer research.
Basic Mechanism of Cancer Biology I
Nucleotide Excision Repair Against Cancer and Premature Aging
Onco-histone Mutations: Mechanisms, Vulnerabilities and Challenges
Discovery of Novel Molecular Targets for Cancer Immunotherapy
Basic Mechanism of Cancer Biology II
Clinical Trials for Brain Tumor in China: Design and Reinnovative Research
Lactic Acid Metabolism-mediated Therapeutic Resistance in Glioblastomas
Metabolic Regulation of Homologous Recombination Repair by Mre11 Lactylation
Lactose and Its Derivatives are a New Class of Immune Checkpoint Inhibitors for Cancer Therapy
Mismatch Repair in Cancer and Cancer Therapy: Discovery of MLH1 and Its Diverse Functions
Therapeutic Approach
Epigenetics in NK Cell Based Immunotherapy
The Challenge of CD7 CAR-T Therapy in Treating T Cell Malignancies
Study on the Epigenetic Mechanism and Targeted Drug Delivery System of Colorectal Cancer
iNKT Cell Therapy for Hepatocellular Carcinoma
New Progress in Comprehensive Treatment Methods of Tumors Associated with Immunotherapy
Blood Cancer
Phenotype-based Translational Study in Acute Myeloid Leukemia
Single-cell Transcriptomics Reveals Chemoresistant Properties in Leukemic Stem Cells in AML
hESC-derived NK and CAR-NK Cells: Basic and Translational Study
The Real Role of Pseudokinase Network: From TRIB3 to Its Partner
Chinese Institutes for Medical Research, Beijing
Beijing Chaoyang Hospital, Capital Medical University
10 Xitoutiao, Youanmen Wai, Fengtai District, Beijing 100069, China
010-86738999
cimr@cimrbj.ac.cn
中文
